Real-time monitoring of additive concentrations in acidic copper plating solution is critical for ensuring process stability and reliability in integrated circuit manufacturing. Traditional detection ...
The FDA approved the first high-concentration adalimumab biosimilar. A low-concentration version of the biosimilar, Hadlima, was already approved. Both versions will launch in July 2023. Last week, ...
Perovskite thin films are key to high-efficiency and low-cost solar and optoelectronic devices. However, when produced at large scale, these films often suffer from uneven crystallization, defects, ...
The WuXiHigh™2.0 technology platform harnesses proprietary excipient blends and expertise to enable concentrations up to 230 mg/mL It reduces viscosity by up to 90% while maintaining formulation ...
High technology company TRUMPF is working with Equispheres Inc. to qualify its aluminum additive manufacturing powders on TRUMPF 3D printers. Equispheres offers three lines of AlSiMg10 powders ...
The old saying, “If a little bit of something is good, then more of the same is better,” is not necessarily true when using oil additives. When the specified concentrations of additives become ...
The US Food and Drug Administration (FDA) has approved the high-concentration, citrate-free formulation of adalimumab-adbm (Cyltezo), a biosimilar of Humira, Boehringer Ingelheim announced. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback